Complimentary shipping over $200 • Extra 6% savings with Debit Card or 8% with Zelle/Cash App

LIMITED TIME OFFER - 15% Off Site-wide!

GLP-1 R 30mg (Research Only)

Original price was: $190.00.Current price is: $161.50.

Contents: 30mg of Retatrutide
Form: Lyophilized Powder

Emerging Research Evidence:

Studied for intensified tri-receptor signaling, hunger-control pathways, weight-management research, and energy-balance markers in lab models.

Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated

Batch-verified inventory. See 3rd Party COA.

In Stock — Order by 4 PM Central Time, ships today

Volume Savings

Select quantity to unlock savings.

Note: Same-product quantities only. Not combinable with BOGO-style promotions. Eligible offers capped at 30% total savings.

Availability: Larger-volume orders are subject to current inventory.

⚠️ Requires Sterile Water for Reconstitution. Type may vary by formulation.
For laboratory use only.

Sale!
Batch: GR30-25191
USA 3rd-Party Tested HPLC-tested verification
99%+ Purity Standard Quality checks for degradation
98%+ Purity Guarantee Money-back below 98%
Fast Protected Delivery Covered if lost or damaged

GLP-1 / GIP / Glucagon Agonist (Retatrutide) Overview

Retatrutide 30mg is an intensive-format triple-pathway analyte utilized in laboratory models to study maximum tri-receptor engagement and the integration of incretin and glucagon-associated signaling. This high-capacity format allows researchers to observe how molecules achieve complete signaling saturation and maintain biochemical harmony within complex metabolic networks. Investigators use this retatrutide compound to track comprehensive hormonal crosstalk and the long-term maintenance of systemic vigor at a molecular level.

Researchers employ Retatrutide to analyze how peak multi-receptor signaling influences the depth of metabolic communication and total caloric-balance modulation. By mapping these high-density triple-receptor cascades, investigators gather technical data on how cells manage advanced metabolic homeostasis and maintain biological agility under high-concentration experimental conditions.

Current studies focus on exploring the mechanisms of saturation-level signal specificity and intensive lipid-utilization patterns. This 30mg vial provides an expanded technical framework for investigating the resilient signaling networks that support metabolic stability, offering a comprehensive look at molecular coordination without focusing on weight loss or therapeutic outcomes.

Retatrutide Structure:

  • CAS Number: 2381089-83-2
  • Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
  • Molecular Weight (average): 4731.34 g/mol
  • Monoisotopic (Exact) Mass: 4728.4718 Da

Parent Compound: N/A – engineered chimeric incretin/glucagon peptide; not derived from a single parent molecule.

Synonyms:

  • LY3437943 (code name)
  • Retatrutide (acetate)
  • 2381089-83-2
  • orb1981169
  • EX-A7826E
  • GTPL13769

Research Areas:

  • Multi-Receptor Endocrine Signaling Research:
    Investigating the coordinated activation and signaling behavior of incretin- and glucagon-associated receptors in laboratory research models.

  • Metabolic Signaling Pathway Studies:
    Examining downstream biomarker modulation and pathway integration related to nutrient-sensing and energy-regulation signaling systems.

  • Hormonal Crosstalk & Receptor Dynamics:
    Studying interactions between multiple endocrine signaling pathways to understand signal integration and regulatory feedback mechanisms.


Condensed Research Summary

Retatrutide 30mg is a high-capacity triple-pathway research analyte used to explore maximum tri-receptor engagement and signaling saturation. In laboratory settings, this concentrated 30mg format allows researchers to observe how high-density interactions coordinate comprehensive hormonal crosstalk and maintain systemic harmony within complex environments. These exploratory studies focus on mapping total caloric-balance modulation and how multi-receptor pathways support peak metabolic stability, providing expanded technical data on signaling behavior without any therapeutic or diagnostic applications.

Research-only note: GLP-1 / GIP / Glucagon Agonist – R is not FDA-approved for therapeutic use; published effects are primarily preclinical and exploratory.

Disclaimer — For Research Purposes Only​

For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.

I am 21 years or older and understand that the products listed on this site are for research purposes only.

Tengo 21 años o más y entiendo que los productos listados en este sitio son solo para fines de investigación.